First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor
Recruiting · NCT07755397 · Registry updated 2026-08-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor | Adenoid Cystic Carcinoma Metastatic; Adenoid Cystic Carcinoma of the Head and Neck; NSCLC Patients With EGFR Activating Mutation | Recruiting | Phase 1 | 2026-08-10 | NCT07755397 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jubilant Therapeutics India Limited | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| All India Institute of Medical Sciences(AIIMS) | New Delhi | India | 1 |
| HCG Manavata Cancer Centre | Nashik | India | 11 |
| Kiran Super Multi-Speciality Hospital | Surat | India | 1 |
| Oncoville Cancer Hospital and Research Center | Bangalore | India | 1 |
| SunAct Cancer Institute Pvt Ltd | Thane | India | 2 |
| Tata Memorial Center | Mumbai | India | 6 |